IRIS - Res&Arch Institutional Research Information System - Research & Archive

PASQUALUCCI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.979
AS - Asia 3.115
EU - Europa 2.646
SA - Sud America 468
Continente sconosciuto - Info sul continente non disponibili 231
AF - Africa 70
OC - Oceania 1
Totale 10.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.883
SG - Singapore 1.451
IE - Irlanda 483
UA - Ucraina 458
HK - Hong Kong 438
IT - Italia 385
RU - Federazione Russa 382
BR - Brasile 363
CN - Cina 336
VN - Vietnam 335
SE - Svezia 271
KR - Corea 187
DE - Germania 157
FR - Francia 157
FI - Finlandia 118
TR - Turchia 80
GB - Regno Unito 75
IN - India 66
CA - Canada 45
BD - Bangladesh 43
AR - Argentina 42
IQ - Iraq 32
MX - Messico 28
PL - Polonia 27
ZA - Sudafrica 21
AT - Austria 20
BE - Belgio 20
NL - Olanda 20
CH - Svizzera 19
UZ - Uzbekistan 19
EC - Ecuador 18
SA - Arabia Saudita 16
ES - Italia 15
JP - Giappone 15
MA - Marocco 15
CO - Colombia 12
PK - Pakistan 12
DZ - Algeria 10
ID - Indonesia 10
LB - Libano 10
GR - Grecia 9
PH - Filippine 9
VE - Venezuela 9
AZ - Azerbaigian 6
CL - Cile 6
EG - Egitto 6
PY - Paraguay 6
GE - Georgia 5
KZ - Kazakistan 5
NP - Nepal 5
PA - Panama 5
PE - Perù 5
TN - Tunisia 5
AL - Albania 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
IL - Israele 4
PS - Palestinian Territory 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
NG - Nigeria 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
EU - Europa 2
HR - Croazia 2
IR - Iran 2
NI - Nicaragua 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
RE - Reunion 1
Totale 10.275
Salva come PNG Salva come JPEG
Città #
Singapore 1.059
San Jose 558
Dublin 483
Chandler 443
Hong Kong 437
Jacksonville 252
San Mateo 251
Ashburn 222
Boardman 203
Dong Ket 202
Seoul 186
Santa Clara 168
Moscow 149
Altamura 135
Perugia 135
Medford 116
Princeton 114
Lauterbourg 109
Ann Arbor 97
Lawrence 90
Wilmington 86
Andover 66
Beijing 64
Izmir 57
New York 53
Los Angeles 49
Ho Chi Minh City 45
Des Moines 43
The Dalles 43
Saint Petersburg 38
Piscataway 32
São Paulo 31
Hanoi 30
Council Bluffs 28
Norwalk 26
Helsinki 21
Nuremberg 21
Brussels 20
Dallas 20
Frankfurt am Main 20
Falls Church 19
Montreal 18
Phoenix 18
Belo Horizonte 17
Woodbridge 17
Amelia 16
Chicago 14
Munich 14
Orem 14
Stockholm 14
Tashkent 14
Tokyo 14
West Jordan 14
Johannesburg 13
Rio de Janeiro 13
San Paolo di Civitate 12
Warsaw 12
Shanghai 11
Baghdad 10
Chennai 10
Dearborn 10
Denver 10
Istanbul 10
Mexico City 10
Amsterdam 9
Brooklyn 9
Columbus 9
Haiphong 9
Houston 9
Guangzhou 8
Hefei 8
London 8
Mumbai 8
Redwood City 8
Toronto 8
Vienna 8
Casablanca 7
Jeddah 7
Nanning 7
Porto Alegre 7
Rome 7
Atlanta 6
Baku 6
Boston 6
Den Haag 6
Dhaka 6
Philadelphia 6
Redmond 6
Secaucus 6
Algiers 5
Charlotte 5
Da Nang 5
Frankfurt Am Main 5
Guarulhos 5
Guayaquil 5
Jakarta 5
Jamaica 5
Medellín 5
Panama City 5
Quito 5
Totale 6.765
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 174
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. 158
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. 151
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. 150
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 146
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 145
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 144
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 140
AID is required for germinal center-derived lymphomagenesis. 131
Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence 127
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. 126
Analysis of the coding genome of diffuse large B cell lymphoma 125
Alterations of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 123
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 122
Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27. 122
BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. 120
BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. 118
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 117
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. 116
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 114
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. 113
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 111
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 111
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. 110
B-cell receptor signaling derailed in lymphomas. 109
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. 109
BRAF mutations in hairy-cell leukemia. 109
Hypermutation of multiple proto-oncogenes in B-cell Diffuse Large Cell Lymphomas 108
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. 108
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 108
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 105
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 105
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. 104
Follicular lymphoma dynamics 100
Targeted antibodies in the treatment of lymphomas. 100
Molecular pathogenesis of germinal center-derived B cell lymphomas 100
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 99
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3ß inhibition 98
Expression of the AID protein in normal and neoplastic B cells. 97
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 96
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. 95
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 95
Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. 93
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. 92
Pathology and Molecular Pathogenesis of DLBCL and Related Entities 91
Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma 88
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression 87
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). 85
Proto-oncogenes and Tumor Suppressor Genes in Hematopoietic Malignancies 85
The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma 85
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. 83
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 83
Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization 83
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. 81
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. 80
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome 79
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis 79
Repurposing Dasatinib for diffuse large B cell lymphoma. 79
Gli anticorpi monoclonali nella terapia delle emopatie maligne. 78
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). 78
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. 78
The genetics of nodal marginal zone lymphoma 78
Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma 78
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. 76
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies. 76
Molecular Biology of Lymphoma 76
Genomic profiling for clinical decision making in lymphoid neoplasms 75
IMMUNOCYTOCHEMICAL DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA (M3) WITH THE ANTI-PROMYELOCYTIC LEUKEMIA (ANTI-PML) MONOCLONAL ANTIBODY PG-M3 75
Emerging epigenetic-modulating therapies in lymphoma 75
Dissecting KMT2D missense mutations in Kabuki syndrome patients 75
Molecular Genetics of Lymphoma 74
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 73
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. 71
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. 70
Genetics of diffuse large b-cell lymphoma 70
Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL 69
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. 69
Molecular pathogenesis of diffuse large B-cell lymphoma 69
The germinal center in the pathogenesis of B cell lymphomas 68
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. 68
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis 68
Genetics of follicular lymphoma transformation. 67
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. 66
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities 65
Immunotoxin therapy of hematological malignancies. 65
Molecular Biology of Lymphoma 64
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas 64
Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells 63
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program 63
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. 63
BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. 63
The genetic landscape of diffuse large B-cell lymphoma 63
null 62
PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. 61
Towards patient-based cancer therapeutics. 61
State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY. 61
Molecular pathogenesis of B cell malignancy: the role of BCL-6. 60
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 60
New approaches to lymphoma diagnosis. 58
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. 58
Totale 9.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022937 0 180 14 61 43 11 14 291 16 35 124 148
2022/20231.607 125 313 23 144 98 170 1 72 604 5 41 11
2023/2024671 33 51 31 11 4 5 174 9 96 31 79 147
2024/20251.593 102 175 20 49 317 51 37 89 323 115 173 142
2025/20263.590 305 226 208 347 393 321 716 181 526 257 86 24
2026/2027162 66 96 0 0 0 0 0 0 0 0 0 0
Totale 10.510